Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Trevor Haynes

Podiatrist, Foot & Ankle Surgery Sandy, OR Doctor of Podiatric Medicine

NPI 1144576224 CMS profile 1221609

37569 Highway 26, Sandy, OR 97055

Open in the dashboard

General payments

$21,369

186 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Trevor Haynes of Sandy, OR is reported in the CMS Open Payments database as having received $21,369 across 186 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $769 28
2024 General $1,040 29
2023 General $1,878 19
2022 General $8,850 40
2021 General $3,298 22
2020 General $2,866 23
2019 General $2,668 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Trevor Haynes
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Trevor Haynes were reported at $769. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Trevor Haynes Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $2,668 $389 $118–$1,406 $163
2020 $2,866 $191 $62–$691 $114
2021 $3,298 $329 $104–$1,341 $132
2022 $8,850 $419 $125–$1,611 $149
2023 $1,878 $377 $128–$1,164 $160
2024 $1,040 $394 $134–$1,168 $164
2025 $769 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $5,806 25 payments
  2. Steelhead Surgical Inc $5,103 12 payments
  3. Treace Medical Concepts, Inc. $4,725 30 payments
  4. Paragon 28, Inc. $1,870 12 payments
  5. Wright Medical Technology, Inc. $1,462 18 payments
  6. Organogenesis Inc. $908 48 payments
  7. Stryker Corporation $236 5 payments
  8. Kuros Biosciences USA, Inc $196 2 payments
  9. Surgenex LLC $167 1 payment
  10. KCI USA, Inc $144 5 payments
  11. Other $754 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $8,144 8 payments
  2. Travel and Lodging $6,910 24 payments
  3. Food and Beverage $6,315 154 payments
Products named General payments · program years 2019–2025
  1. LAPIPLASTY SYSTEM Foot And Ankle $2,463 15 payments
  2. Lapiplasty System Y $2,082 12 payments
  3. PROstep $995 11 payments
  4. ORTHOLOC $447 6 payments
  5. Product Portfolio $400 3 payments
  6. Puraply $196 10 payments
  7. MAGNETOS $196 2 payments
  8. SurMatrix $167 1 payment
  9. PelloGraft $167 1 payment
  10. ArdeoGraft $167 1 payment
  11. Other $2,521 78 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

80

Median for Podiatry: 160

Drug cost

$571

Median for Podiatry: $2,368

Branded share of claims

0%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 24 $160
Oxycodone Hcl Generic 21 $136
Terbinafine Hcl Generic 11 $108
Cephalexin Generic 13 $106
Doxycycline Hyclate Generic 11 $62

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$1,192,362

Of which drugs: $1,125,561

Medicare patients

246

Average age 76

Services billed

1,704

133 women, 113 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 49%
Diabetes 42%
Chronic kidney disease 30%
Ischemic heart disease 26%
Atrial fibrillation 26%
Depression 26%
Heart failure 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

186 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record